We first report the prognostic efficacy of a systematic TES model for COAD patients compared to previously presented T-cell exhaustion markers (HAVCR2, ENTPD1, LAYN, and LAG3). This evidence concerns the gene ENTPD1 and colon adenocarcinoma.